Correlation Between PDS Biotechnology and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Syndax Pharmaceuticals, you can compare the effects of market volatilities on PDS Biotechnology and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Syndax Pharmaceuticals.
Diversification Opportunities for PDS Biotechnology and Syndax Pharmaceuticals
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between PDS and Syndax is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Syndax Pharmaceuticals
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Syndax Pharmaceuticals. In addition to that, PDS Biotechnology is 2.6 times more volatile than Syndax Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.12 per unit of volatility. If you would invest 1,424 in Syndax Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 104.00 from holding Syndax Pharmaceuticals or generate 7.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
PDS Biotechnology Corp vs. Syndax Pharmaceuticals
Performance |
Timeline |
PDS Biotechnology Corp |
Syndax Pharmaceuticals |
PDS Biotechnology and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PDS Biotechnology and Syndax Pharmaceuticals
The main advantage of trading using opposite PDS Biotechnology and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.PDS Biotechnology vs. Mereo BioPharma Group | ||
PDS Biotechnology vs. Terns Pharmaceuticals | ||
PDS Biotechnology vs. Inozyme Pharma | ||
PDS Biotechnology vs. Hookipa Pharma |
Syndax Pharmaceuticals vs. Cogent Biosciences | ||
Syndax Pharmaceuticals vs. Cullinan Oncology LLC | ||
Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | ||
Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |